Should (and could) we measure portal pressure in clinical practice?

Gastroenterology International

Volumn 15, Issue 3-4, 2002, Pages 51-57

  Puoti, C ^a,b   Bellis, L ^a  

^a Ospedale E De Santis   (Italy)

^b E De Santis Hospital   (Italy)

Author keywords

Cirrhosis; Esophageal varices; Hepatic venous pressure gradient; Portal pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLOOD PRESSURE MEASUREMENT; CLINICAL PRACTICE; DISEASE SEVERITY; ESOPHAGUS VARICES BLEEDING; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; PATIENT MONITORING; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; VENOUS PRESSURE;

EID: 0141681340     PISSN: 09505911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003;38:S54-8.
2. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-80.
3. Bosch J, Garcia Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32 (Suppl 1):141-56.
4. de Franchis R, editor. Portal hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science; 2000.
5. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-91.
6. Bathal PS, Grozsmann RJ. Reduction of the increased portal vascular resistance of the isolated cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-9.
7. Bosch J, Garcia-Pagan JC. Pathophysiology of portal hypertension and its complications. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J, editors. Oxford Texbook of Clinical Hepatology. Oxford: Oxford University Press; 1999. p.653-9.
8. Garcia-Tsao G, Groszmann RJ, Fischer RL, Conn HO, Atterbury J, Glickmann M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-24.
9. Groszmann RJ. Reassessing portal pressure measurements. Gastroenterology 1984;86:1611-7.
10. De Plano A, Migaleddu V, Pischedda A, Garrucciu G, Gregu G, Cossu PA, et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci 1999;44:155-62.
11. Perellò A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagàn JC, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999;30:1393-7.
12. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
13. Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodés J, Bosch J. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000;31:1061-7.
14. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996;111:701-9.
15. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-44.
16. Schepis F, Cammà C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection. Hepatology 2001;33:333-8.
17. D'Amico G, Luca A. Natural history. Clinical-hemodynamic correlations. Prediction of the risk of bleeding. Baillieres Best Pract Res Clin Gastroenterol 1997;11:243-56.
18. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505.
19. de Franchis R Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645-63.
20. Vinel JP, Cassigneul J, Louis A, Levade M, Pascal JP. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gyn Obstet 1982;155:347-52.
21. Gluud C, Henriksen JH, Nielsen G and the Copenhagen Study Group for Liver Disease. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988;8:222-7.
22. Garcia-Pagan JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991;114:869-73.
23. Villanueva C, Balanzo J, Novella MT, Soriano G, Sains S, Torras X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996;334:1624-9.
24. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-9.
25. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930-4.
26. Abraldes J, Tarantino I, Turnes J, Garcia-Pagan JC, Rodès J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902-8.
27. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodés J, et al. Prognostic value of early measurement of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626-31.
28. Garcia-Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics. Basis of its use in the treatment of portal hypertension. Semin Liv Dis 1999;19:427-38.
29. Zimmon DS, Manheimer F. Blind beta blockade. Hepatology 2001;34:847-8.
30. Bellis L, Berzigotti A, Abraldes JG, Moitinho E, Garcia-Pagan JC, Bosch J, et al. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis. Hepatology 2003;37:378-84.
31. Bureau C, Peron JM, Alric L, Morales J, Sanchez J, Barange K, et al. 'A la carte' treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;36:1361-6.
32. Bosch J. A la carte or menu fixe: improving pharmacologic therapy of portal hypertension. Hepatology 2002;36:1330-1.
33. Merkel C, Bolognese M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992;102:973-9.
34. Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H. Plasma catecholamine levels and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988;6:350-8.
35. Patch D, Armonis A, Sabin C, Christopoulou K, Greenslade L, McCormick A, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999;44:264-9.
36. Izumi R, Shimizu K, Li T, Yagi M, Matsicui O, Nonamura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-7.
37. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-22.
38. Sanyal AJ. Hepatic Venous Pressure Gradient: to measure or not to measure, that is the question. Hepatology 2000:31:1175-6.
39. Groszmann RJ. The hepatic venous pressure gradient: has the time arrived for its application in clinical practice? Hepatology 1996;24:739-41.
40. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-4.